Formycon and Zydus Say FDA Accepts FYB206 Biosimilar for Review
Formycon and Zydus said FYB206 is the first publicly announced Keytruda biosimilar accepted for FDA review.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Formycon and Zydus said FYB206 is the first publicly announced Keytruda biosimilar accepted for FDA review.